ACTIVE

OSIVAX Belgique

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-2,8 M €-10,3 %over 1 year

Gross margin3,9 M €+241,7 %over 1 year

Equity13,3 M €-17,5 %over 1 year

Workforce8,7 ETP+22,5 %over 1 year

Identity

Source · BCE/KBO

OSIVAX Belgique is a Private limited company incorporated in 2018. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Liège. It employs on average 8,7 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0707.772.871
Incorporation: 04/10/2018
Legal form: Private limited company
Registered office: Rue des Chasseurs-Ardennais 7
4031 Liège · WallonieSee on map
Contributed capital: 16 176 732,28 €
Latest accounts: 31/12/2025
Average workforce: 8,7 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology

Joint committees (1)

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 7 filings

Trend over 6 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	3,9 M €	+242%	1,1 M €	+3.0%	1,1 M €	-38.2%	1,8 M €	+111%	850,5 k €
EBITDA	2,6 M €	+1644%	146,6 k €	-75.8%	604,8 k €	-57.8%	1,4 M €	+153%	565,3 k €
Operating result	-3,2 M €	+3.6%	-3,3 M €	-14.7%	-2,9 M €	+1.6%	-2,9 M €	-38.3%	-2,1 M €
Net result	-2,8 M €	-10.3%	-2,6 M €	+10.7%	-2,9 M €	+1.4%	-2,9 M €	-38.5%	-2,1 M €
Balance sheet
Equity	13,3 M €	-17.5%	16,2 M €	+81.3%	8,9 M €	-18.4%	10,9 M €	+5.1%	10,4 M €
Total assets	17 M €	-7.9%	18,4 M €	+65.3%	11,1 M €	-23.2%	14,5 M €	+11.6%	13 M €
Cash	1,5 M €	+121%	664,8 k €	-4.4%	695,5 k €	-38.5%	1,1 M €	+88.0%	601,1 k €
Debts	3,6 M €	+61.8%	2,2 M €	+0.9%	2,2 M €	-38.0%	3,6 M €	+38.1%	2,6 M €
Other
Workforce	8,7 ETP	+22.5%	7,1 ETP	+14.5%	6,2 ETP	+31.9%	4,7 ETP	+2.2%	4,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
OSIVAX SASRepresented by LEVERT ALEXANDRE	Directorsince 24/09/2020

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
HLB NICOLET & C°0876.193.377Represented by Jean NICOLET	Registered auditorlisted until the 2020 accounts
Luzac InnovationRepresented by Alexandre Levert	Director24/12/2020 → 2024 accounts

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/10/2026	24/06/2025	26/08/2024	19/09/2023	31/08/2022	19/07/2021
General meeting	19/06/2026	20/06/2025	21/06/2024	16/06/2023	17/06/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 7 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	19/06/2026	14/10/2026	French	PDF
Abridged model	31/12/2024	20/06/2025	24/06/2025	French	PDF
Abridged model	31/12/2023	21/06/2024	26/08/2024	French	PDF
Abridged model	31/12/2022	16/06/2023	19/09/2023	French	PDF
Abridged model	31/12/2021	17/06/2022	31/08/2022	French	PDF
Abridged model	31/12/2020	18/06/2021	19/07/2021	French	PDF
Abridged model	31/12/2019	19/06/2020	17/07/2020	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
OSIVAX SASRepresented by LEVERT ALEXANDRE	Directorsince 24/09/2020

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
HLB NICOLET & C°0876.193.377Represented by Jean NICOLET	Registered auditorlisted until the 2020 accounts
Luzac InnovationRepresented by Alexandre Levert	Director24/12/2020 → 2024 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other10/12/2024
DIVERS
PDF
Mandates26/06/2024
DEMISSIONS, NOMINATIONS
PDF
Other12/09/2022
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates11/05/2021
DEMISSIONS, NOMINATIONS
PDF
Registered office05/05/2021
SIEGE SOCIAL
PDF
Mandates12/01/2021
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Mandates27/11/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates11/03/2020
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings6 filings

Mandates

OSIVAX SAS

HLB NICOLET & C°

Luzac Innovation

ALEXANDRE LE VERT

OSIVAX SAS S. Etr.

OSIVAX SAS S ETR

201820192020202120222023202420252026

OSIVAX Belgique

Rue des Chasseurs-Ardennais 7, 4031 Angleur

Director

Manager

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue des Chasseurs-Ardennais 7, 4031 AngleurCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00560510

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
OSIVAX BelgiqueCurrent	accounts 2019 → 2025	Accounts 2025 · 2026-00560510

Events

2025
Annual accounts 2025-2,8 M €↓
2024
Annual accounts 2024-2,6 M €↑
2023
Annual accounts 2023-2,9 M €↑
2022
Annual accounts 2022-2,9 M €↓
2021
Annual accounts 2021-2,1 M €↓
2019
Annual accounts 2019-1,4 M €
04/10/2018
IncorporationPrivate limited company

OSIVAX Belgique

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events